Abingdon Health Management
Management criteria checks 2/4
Abingdon Health's CEO is Chris Henry Yates, appointed in Jul 2015, has a tenure of 9.33 years. total yearly compensation is £323.00K, comprised of 82.7% salary and 17.3% bonuses, including company stock and options. directly owns 2.05% of the company’s shares, worth £571.94K. The average tenure of the management team and the board of directors is 1.8 years and 12.7 years respectively.
Key information
Chris Henry Yates
Chief executive officer
UK£323.0k
Total compensation
| CEO salary percentage | 82.7% |
| CEO tenure | 9.3yrs |
| CEO ownership | 2.0% |
| Management average tenure | 1.8yrs |
| Board average tenure | 12.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | UK£323k | UK£267k | -UK£1m |
| Mar 31 2024 | n/a | n/a | -UK£2m |
| Dec 31 2023 | n/a | n/a | -UK£2m |
| Sep 30 2023 | n/a | n/a | -UK£3m |
| Jun 30 2023 | UK£278k | UK£225k | -UK£3m |
| Mar 31 2023 | n/a | n/a | -UK£11m |
| Dec 31 2022 | n/a | n/a | -UK£18m |
| Sep 30 2022 | n/a | n/a | -UK£20m |
| Jun 30 2022 | UK£222k | UK£203k | -UK£21m |
| Mar 31 2022 | n/a | n/a | -UK£17m |
| Dec 31 2021 | n/a | n/a | -UK£12m |
| Sep 30 2021 | n/a | n/a | -UK£10m |
| Jun 30 2021 | UK£455k | UK£251k | -UK£7m |
| Mar 31 2021 | n/a | n/a | -UK£5m |
| Dec 31 2020 | n/a | n/a | -UK£3m |
| Sep 30 2020 | n/a | n/a | -UK£3m |
| Jun 30 2020 | UK£228k | UK£213k | -UK£3m |
Compensation vs Market: Chris Henry's total compensation ($USD409.49K) is about average for companies of similar size in the UK market ($USD356.13K).
Compensation vs Earnings: Chris Henry's compensation has increased whilst the company is unprofitable.
CEO
Chris Henry Yates (50 yo)
9.3yrs
Tenure
UK£323,000
Compensation
Mr. Chris Henry Francis Yates has been Independent Non-Executive Director of genedrive plc since August 22, 2018. He Co-Founded diagnostics group Abingdon Health (“Abingdon”) in 2008 and he has been the Ch...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 16.8yrs | UK£89.00k | 3.42% £ 1.0m | |
| CEO, Company Secretary & Director | 9.3yrs | UK£323.00k | 2.05% £ 611.4k | |
| Group Financial Controller | less than a year | no data | no data | |
| Chief Operating Officer | 2.7yrs | no data | no data |
1.8yrs
Average Tenure
Experienced Management: ABDX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 16.8yrs | UK£89.00k | 3.42% £ 1.0m | |
| CEO, Company Secretary & Director | 12.7yrs | UK£323.00k | 2.05% £ 611.4k | |
| Senior Independent Non-Executive Director | 4.1yrs | UK£41.00k | no data | |
| Member of Medical & Scientific Advisory Board | no data | no data | no data | |
| Member of Medical & Scientific Advisory Board | no data | no data | no data | |
| Member of Medical & Scientific Advisory Board | no data | no data | no data | |
| Member of Medical & Scientific Advisory Board | no data | no data | no data |
12.7yrs
Average Tenure
62yo
Average Age
Experienced Board: ABDX's board of directors are seasoned and experienced ( 12.7 years average tenure).